% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • slned slned Jun 25, 1998 11:44 AM Flag


    (abacavir), a nucleoside analog reverse
    transcriptase inhibitor which appears "to have greater
    antiviral activity than other drugs in this class". (see
    Glaxo W's PR today 10:46 EST)

    Looks like Glaxo
    W. is working to market the whole cocktail with all
    of the X resistance, etc, sequences studied in Ph
    III, plus offer more effective analogs. Any clinicians
    out there who would have something to say about using
    the Glaxo suite of anti retrovirals since adverse
    event profiles, resistance, peds dosing, etc. etc.
    combo concerns being studied in PH III when
    co-developed by one comapny? (Amprenavir is VRTX +_Glaxo W)

90.38+1.19(+1.33%)May 27 4:00 PMEDT